Australia markets closed

Cyclacel Pharmaceuticals, Inc. (CYCC)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.4900-0.1600 (-6.04%)
At close: 04:00PM EDT
2.2800 -0.21 (-8.43%)
After hours: 07:58PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
420
420
0
0
0
Operating expenses
Research development
19,155
19,155
20,274
14,928
4,759
Selling general and administrative
6,718
6,718
7,382
7,461
5,877
Total operating expenses
25,873
25,873
27,656
22,389
10,636
Operating income or loss
-25,453
-25,453
-27,656
-22,389
-10,636
Total other income/expenses net
-364
-364
1,531
188
913
Income before tax
-25,551
-25,551
-25,915
-22,185
-9,681
Income tax expense
-2,996
-2,996
-4,717
-3,728
-1,236
Income from continuing operations
-22,555
-22,555
-21,198
-18,457
-8,445
Net income
-22,555
-22,555
-21,198
-18,457
-8,445
Net income available to common shareholders
-22,756
-22,756
-21,399
-18,658
-12,421
Basic EPS
-29.85
-26.75
-28.70
-32.10
-51.30
Diluted EPS
-29.85
-26.75
-28.70
-32.10
-51.30
Basic average shares
838.137
850.815
657.62
595.078
242.225
Diluted average shares
838.137
850.815
657.62
595.078
242.225